News & PR
플랫폼 기술기반 First-in-Class 신약개발 전문 기업
보도자료
[24.07.31] Aptabio Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate ‘APX-343A’ in Combination with KEYTRUDA® (pembrolizumab)
-
- 작성일
- 2024-08-01 09:40:38
-
- 조회수
- 2365
